Literature DB >> 14102085

PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).

G MARTZ, A D ALESSANDRI, H J KEEL, W BOLLAG.   

Abstract

Keywords:  ANTINEOPLASTIC AGENTS; BONE MARROW DISEASES; EOSINOPHILIA; GERIATRICS; HEMOLYSIS; HODGKIN'S DISEASE; HYDRAZINES; LEUKEMIA, LYMPHOCYTIC; LYMPHOCYTOSIS; LYMPHOMA, GIANT FOLLICULAR; LYMPHOSARCOMA; NAUSEA; NEOPLASM THERAPY; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT; VOMITING

Mesh：

Substances：

Year:  1963        PMID： 14102085

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  5 in total

1.  [Long term treatment of advanced vinblastine-resistant lymphogranulomatosis with ibenzmethyzin (Natulan)].

Authors:  E Schulz; H Cissée; K Hausmann
Journal:  Klin Wochenschr       Date:  1970-11-01

2.  A genetic effect of symmetric dimethylhydrazine: induction of mitotic recombination.

Authors:  F K Zimmermann; R Schwaier
Journal:  Naturwissenschaften       Date:  1967-05

3.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

4.  BIOTRANSFORMATION OF HYDRAZINE DERVATIVES IN THE MECHANISM OF TOXICITY.

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2014-07-08

5.  DNA cleavage and detection of DNA radicals formed from hydralazine and copper (II) by ESR and immuno-spin trapping.

Authors:  Birandra K Sinha; Fabian Leinisch; Suchandra Bhattacharjee; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2014-02-13       Impact factor: 3.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.